L3F

(phenylmethyl) N-[(2S)-3-methyl-1-oxidanylidene-1-[[(2S)-1-oxidanyl-3-phenyl-propan-2-yl]amino]butan-2-yl]carbamate

Created:	2022-06-14
Last modified:	2024-09-27

Find Related PDB Entry
1 entries where L3F is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	56
Chiral Atom Count	2
Bond Count	57
Aromatic Bond Count	12

2D diagram of L3F

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(phenylmethyl) N-[(2S)-3-methyl-1-oxidanylidene-1-[[(2S)-1-oxidanyl-3-phenyl-propan-2-yl]amino]butan-2-yl]carbamate
Synonyms	benzyl N-[(2S)-1-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamate; calpain inhibitor III
Systematic Name (OpenEye OEToolkits)	(phenylmethyl) ~{N}-[(2~{S})-3-methyl-1-oxidanylidene-1-[[(2~{S})-1-oxidanyl-3-phenyl-propan-2-yl]amino]butan-2-yl]carbamate
Formula	C₂₂ H₂₈ N₂ O₄
Molecular Weight	384.469
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	CC(C)[CH](NC(=O)OCc1ccccc1)C(=O)N[CH](CO)Cc2ccccc2
SMILES	OpenEye OEToolkits	2.0.7	CC(C)C(C(=O)NC(Cc1ccccc1)CO)NC(=O)OCc2ccccc2
Canonical SMILES	CACTVS	3.385	CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](CO)Cc2ccccc2
Canonical SMILES	OpenEye OEToolkits	2.0.7	CC(C)[C@@H](C(=O)N[C@@H](Cc1ccccc1)CO)NC(=O)OCc2ccccc2
InChI	InChI	1.06	InChI=1S/C22H28N2O4/c1-16(2)20(24-22(27)28-15-18-11-7-4-8-12-18)21(26)23-19(14-25)13-17-9-5-3-6-10-17/h3-12,16,19-20,25H,13-15H2,1-2H3,(H,23,26)(H,24,27)/t19-,20-/m0/s1
InChIKey	InChI	1.06	VLFHBNSJHLMKMM-PMACEKPBSA-N

Related Resource References

Resource Name	Reference
PubChem	9843057

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.